Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...
Activist investor Starboard Value takes $1 bln stake in Pfizer, sources say
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make ...
FiercePharma8h
Dupixent takes pharma DTC top spot as Pfizer's COVID drug Paxlovid makes a comeback
AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...
STAT3d
After a rocky debut for new RSV tools, hopes are high as a new season approaches
Spread of the virus is seasonal, with activity often picking up in the fall after kids go back to school. Activity usually ...
Pfizer shares jump on $1 bln activist investor stake
STORY: Shares of Pfizer rose as much as four percent in Monday morning trading after activist investor Starboard Value took ...
Making an RSV Vaccine Was Hard. Getting People to Take It Is Even Harder
RSV hospitalizes thousands of people in the US every year. Three new vaccines could help stem the spread, but there are ...
EconoTimes19h
Activist Investor Starboard Value Takes $1B Stake in Pfizer, Calls for Strategic Overhaul
Activist investor Starboard Value has acquired a $1 billion stake in Pfizer to push for strategic changes in the U.S.
KSL3d
What to know about the RSV immunization for babies
As many as 80,000 children under 5 are hospitalized each year due to the respiratory syncytial virus, according to the CDC.